BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/1/2024 7:39:37 AM | Browse: 84 | Download: 335
 |
Received |
|
2024-03-06 03:37 |
 |
Peer-Review Started |
|
2024-03-06 03:37 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-04-22 21:14 |
 |
Revised |
|
2024-05-07 05:52 |
 |
Second Decision |
|
2024-06-13 02:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-06-13 05:50 |
 |
Articles in Press |
|
2024-06-13 05:50 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-06-20 00:52 |
 |
Publish the Manuscript Online |
|
2024-07-01 07:39 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen and Jie-Xiong Feng |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
No. 81873541 |
|
Corresponding Author |
Jie-Xiong Feng, MD, PhD, Chief Doctor, Doctor, Doctor, Professor, Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave, Wuhan 430030, Hubei Province, China. 2002tj0515@hust.edu.cn |
Key Words |
Nonalcoholic fatty liver disease; Metabolic dysfunction-associated fatty liver disease; Alanine aminotransferase; Screening; Risk marker |
Core Tip |
This editorial discusses the article by Chen et al regarding the association between high-normal alanine aminotransferase (ALT) levels and the onset of metabolic dysfunction-associated fatty liver disease (MAFLD) in China. As an indicator of liver function, ALT could be considered a marker of the presence of MAFLD. Therefore, tracking cumulative ALT levels could enhance early MAFLD detection. Improved detection through ALT tracking could enable timely intervention, thereby enhancing overall health outcomes for individuals at risk of developing this increasingly common liver condition. |
Publish Date |
2024-07-01 07:39 |
Citation |
<p>Wang D, Zhou BY, Xiang L, Chen XY, Feng JX. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. <i>World J Gastroenterol</i> 2024; 30(25): 3132-3139</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i25/3132.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i25.3132 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345